Industry & Policy News

[Oregon Health & Science University] Dr. Alexis Gibson, a Postdoctoral researcher at Oregon Health & Science University, is the recipient of a 2023 Howard Hughes Medical Institute, or HHMI, Hanna Gray Fellowship. The prestigious award recognizes talented early career scientists in the biomedical sciences.

[Tuskegee University] Tuskegee University College of Veterinary Medicine researcher Dr. Deepa Bedi was issued a US Patent for her methods for identifying aggressive breast cancer cells.

[Nature News] The US biomedical agency tweaked its new policy after an outcry from researchers, but will forge ahead.

[Corsair Pharma, Inc.] Corsair Pharma, Inc. announced the closing of its $23M Series B financing led by New Rhein Healthcare Investors. Proceeds from the financing will support the clinical advancement of Corsair’s lead product candidate, a prodrug of treprostinil delivered in a proprietary transdermal patch to treat Pulmonary Arterial Hypertension.

[National Insitute on Aging] The Breakthrough Prize Foundation has announced Andrew B. Singleton, Ph.D., a distinguished investigator at NIH as one of three recipients of the 2024 Breakthrough Prize in Life Sciences.

[Predicine, Inc.] In this global Phase I clinical trial of Divarasib, Predicine’s tumor-naïve, blood-informed minimal residual disease solution, PredicineBEACON™, played a central role in assessing the safety and efficacy of the treatment of non-small cell lung cancer, colorectal cancer, and other solid tumors at the highest dose.